Congress Overwhelmingly Signs-On to 2013 SDP Support Letter
The bipartisan Special Diabetes Program (SDP) support letter was recently circulated by Congressional Diabetes Caucus Co-Chairs, and JDRF Advocates helped drive home the importance of the program with their Members. Advocates from around the country asked their Representative and Senators to sign-on to this important SDP support letter, and they did so in record numbers. The final letter saw 336 House Members (more than 75% of the body) and 76 Senators (also more than 75% of the body) sign-on. Click on the House and Senate links above to see whether your Members joined in public support of the SDP. And if you’d like to follow-up with a Member office to say ‘thank you’, please do so here now.
For perspective, in 2012, 72 Senators and 272 House Members signed similar SDP support letters circulated by Caucus Co-Chairs Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME), and Reps. Ed Whitfield (R-KY) and Diana DeGette (D-CO), Tom Reed (R-NY) and Xavier Becerra (D-CA). Thanks to these leaders and to advocates from all over the T1D community, the SDP renewal effort enjoys strong bipartisan support.
As you may know, JDRF worked hard to help secure a one-year renewal of the SDP that was included in the ‘American Taxpayer Relief Act of 2012’ legislation, which passed at the end of the last Congress. Many Members of Congress from both parties and on both sides of the Capitol helped us to pass this important renewal of the SDP during the last Congress. The 113th Congress will once again be critical, as we need the program to be renewed for a multiple-year period of 3 years, fully funded at $150 million per year, in order for ground-breaking research to continue, and for critical advancements to be made. Thank you in advance from JDRF Advocacy for calling upon your federal legislators - and letting them know just how important this program is to you, and to the future of all those with T1D.
What is the Special Diabetes Program (SDP)?
In recognition of an alarming trend, Congress formed the Diabetes Research Working Group in 1997, which reported serious limitations in diabetes research – for type 1 diabetes (T1D) in particular – largely due to inadequate funding. In light of the working group’s report, Congress created the SDP, a program made up of two parts: one to advance T1D research at the National Institutes of Health (NIH), and the other to fund treatment, education, and prevention programs for American Indian and Alaska Native populations, who are disproportionately affected by type 2 diabetes.
Real Progress, Real Results: Since its inception, the SDP has demonstrated tangible results. The program has enabled scientists to make significant advances in cure therapies, prevention studies and treatment improvements (including the Artificial Pancreas Project and groundbreaking advances in vision improvement among people with diabetic eye disease), and is an essential component of federal investment in diabetes research. The SDP is funded at $150 million per year, and is currently operational until September 2014, with the one-year renewal put in place at the end of 2012. However, multiple-year funding must be established in the future to continue large-scale trials, proactively plan next steps to maximize research opportunities, and to most effectively allocate research dollars without interruption.
Renew the SDP
Renewal of the SDP remains JDRF’s top federal legislative priority for this year. This program has enjoyed strong bipartisan support from Congress since its inception, it has proven itself to be worthy of federal investment as it is improving the lives of those who have diabetes, and it will help reduce healthcare costs for our country in the long-term. This critical program provides nearly 35% of the publicly-funded type 1 diabetes research at NIH. Without a timely multi-year fully-funded renewal of the program, clinical trials will slow down or halt altogether, and JDRF will not be able to fill the gap.
To learn more about the importance of renewing the SDP, please read our SDP brochure and our individual fact sheets below:
- The Special Diabetes Program Brochure
- A Federal Program that Works
- Highlights from NIH Report
- Why Renew Now
- Preventing Kidney Disease
- Helping Patients Beyond T1D
- Economic Benefits
- Potential Savings to Medicare
- Frequently Asked Questions (FAQ)
What Can I Do as an Advocate?
Sign-up to be an advocate if you aren’t already, and take action when you see our alerts. Your voice will help make a difference. If you would like others to learn more about the SDP, please share this page with your friends, family, neighbors and coworkers, and link to our pages on social media sites such as Facebook, Twitter, Instagram and YouTube. For further updates, please check back with us often at this advocacy page. Thank you for all that you do.